← Open Payments lookup

ASSAD DARAWAL: Open Payments

NPI 1902877301 · INDIO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$962 in 46 payments from 18 companies in 2025. Trend: 2023 $853 · 2024 $1,128 · 2025 $962

Food & beverage: $962
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$330
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$122
Bayer Healthcare Pharmaceuticals Inc.5$81
Otsuka America Pharmaceutical, Inc.3$71
GlaxoSmithKline, LLC.3$46
E.R. Squibb & Sons, L.L.C.2$44
Novo Nordisk Inc2$39
Electromed, Inc.2$36
Boehringer Ingelheim Pharmaceuticals, Inc.1$32
PFIZER INC.1$30

Products named: AIRSUPRA, XIFAXAN, Kerendia, REXULTI, FARXIGA, TRELEGY ELLIPTA, ELIQUIS, Wegovy.

Industry payments across CA — which companies pay providers there.